StockWatch
·

BATA INDIA LTD. Q2 FY27 Results

BATAINDIAQ2 FY27 Results
Filing
Result:Weak· Market: Down#Base effect#Margin squeeze

Outlook: Cautiously Optimistic · Guidance: None

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue861.7812.0%7.5%
Total Income879.8411.8%6.9%
Expenditure855.146.1%7.5%
PBT24.7071.3%28.0%
Net Profit18.1271.7%30.4%
OPM16.69%4.15pp0.37pp
NPM2.06%4.36pp0.37pp
EPS1.4171.7%30.6%
View full financials

Core retail metrics are soft — revenue growth a modest 7.5% with a steep QoQ fall, EBITDA margin compressed to ~16.7% from ~17.1% YoY (and sharply from ~20.8% in Q1), and adjusted PAT (stripping the prior-year VRS one-off) is down ~9% YoY despite the flattering 30.4% reported PAT growth.

BATA INDIA LTD. · Q2 FY-2027 · THE VERDICT

Pricing Power, Volume Drought—and a Credibility Test for the New MD

Revenue grew 7.5% YoY, but 100% of it was ASP-driven; volume growth stalled at 1.5-2%. More troubling: PAT halved quarter-on-quarter to a razor-thin 2.1% net margin. The new MD's 'double India 2030' ambition is credible in spirit but lacks quantified milestones to earn belief.

09 Nov 2026 · 6 min read
Revenue

₹861.8 Cr

+7.5% YoY, -12.0% QoQ

Net profit

₹18.1 Cr

+30.4% YoY, -71.7% QoQ

Operating margin

16.7%

Net margin 2.1% (razor-thin)

ASP growth

+5-6%

Pricing power clear

Volume growth

~1.5-2%

Implied; nearly flat demand

The Real Tension: ASP Masking Volume Stall

Headline revenue of +7.5% YoY appears respectable. Dig one level deeper: the entire growth came from price increases (ASP up 5-6%). Volume growth—unit sales—was negligible, around 1.5-2%. In a quarter when management highlighted 45 million annual consumer footfalls and availability up 33% year-on-year, that volume result is not healthy. It signals weak demand elasticity or competitive share loss masked by pricing.

Revenue growth contribution, %
02.615.237.845.5ASP growth1.5Volume growth (implied)7Total
The 7.5% top-line growth is entirely driven by price; volume growth (1.5–2%) is negligible, suggesting weak demand.

The Earnings Quality Red Flag: PAT Halves Quarter-on-Quarter

While revenue looks steady, profit tells a different story. Q2 PAT of ₹18.1 Cr is down 71.7% quarter-on-quarter—that's a collapse. Yes, it's up 30.4% year-on-year, but the year-ago base was depressed. More concerning: net profit margin sits at just 2.1%, razor-thin for a ₹862 Cr revenue quarter. This despite gross margin expanding 70 basis points from Q1 to Q2. The math suggests one of two things: (1) working capital drag (inventory aging, payables pressure), or (2) unspoken costs or one-time expenses that management did not reconcile on the call. The CFO's claim of 'range-bound' margins and caution on commodity/FX volatility hints at ongoing headwinds that are eating into net profit faster than gross margin expansion can offset.

Management Claims vs. What the Numbers Actually Show

ASP-led growth of 5-6% YoY, with fresh inventory at 84-85% premium mix

Revenue +7.5% YoY confirmed; implies volume ~1.5-2%; inventory metrics supported

Supported

Adjusted PBT grew over 31% YoY

Reported PAT +30.4% YoY; QoQ down -71.7%. 'Adjusted' divergence not explained

Overstated (earnings quality issue)

Gross margin improved ~70 bps Q1 to Q2

OPM 16.7%, confirmed; absolute margin expansion real but thin bottom-line

Supported

ASP gradual uplift & volume modest but healthy

ASP +5-6% confirmed; volume ~1.5-2% is flat/stalled, not healthy

Overstated (demand weak)

Inventory aging close to 5%, stock turn higher than 2.6

WC discipline evident; fresh inventory 84-85% high

Supported

What Changed on This Call

New MD, new ambition. Sanjay Rao, global hire, 72 days into the role, articulated a structural transformation agenda: 'Reignite India 2030' (ambition to double top line and profits over the next 4 years at mid-single to double-digit CAGR). Vendor consolidation (120 partners down to 30 over 3–5 years) targets 200 basis points of gross margin uplift. A&P spend stepped up 4% YoY, targeting 3–3.5% of sales (up from prior 2.5%), to back product launches (sneaker category, global lines for Gen-Z) in H2 FY27. Franchisee store expansion promised at double-digit pace. None of this is new in spirit—the prior CEO spoke of margin uplift and premiumization too—but the tone is fresher, the global input credible, and the ambition louder. The question is execution: the 10-year track record under the prior leadership is near-flat CAGR, which creates a credibility gap.

The Bull-Bear Ledger
  • Pricing power evident: ASP +5-6% in deflationary context

  • Availability up 33% YoY; fresh inventory premium mix (84-85% high)

  • Gross margin up 70 bps Q1→Q2 despite channel mix headwinds

  • Franchisee growth double-digit; strategic for geographic reach

  • New MD brings global best practices; vendor consolidation (200 bps uplift target) is structural

  • Volume growth stalled at 1.5-2%; demand elasticity weak

  • PAT down 71.7% QoQ to ₹18.1 Cr; NPM 2.1% razor-thin

  • Adjusted PBT claim (+31% YoY) not reconciled with headline PAT (+30.4%)

  • New MD unproven; 10-year prior track record near-flat CAGR

  • Vendor consolidation (200 bps uplift) takes 3-5 years; benefits not yet realized

  • Channel mix shift (franchisee/e-com lower-margin) structurally reduces profitability

  • Commodity/FX volatility uncontrollable; CFO explicitly cautious on 'range-bound' margins

Risks, Ranked by How Much They Should Concern a Holder

Volume growth deferred; H2 product launches may not land

High

Q2 volume flat (~1.5-2%) despite 45M footfalls and 33% availability uplift. New products (sneaker, global lines) promised in H2 FY27 to drive recovery, but execution timing uncertain. If volume doesn't accelerate, 4-year CAGR targets (mid-single to double-digit) are unachievable.

Earnings quality: PAT margin collapse despite gross margin expansion

High

PAT down 71.7% QoQ to ₹18.1 Cr; NPM 2.1% is structurally thin. Gross margin up 70 bps Q1→Q2, yet bottom line halved. Suggests WC drag or unspoken costs. If this is the new baseline, profitability recovery is much harder than headline growth suggests.

New MD credibility gap; 10-year execution track record near-flat

High

Sanjay Rao 72 days into role; global hire with fresh ambition ('double India 2030'). However, prior CEO oversaw decade of near-flat CAGR. Ambition lacks quantified FY-by-FY milestones; analysts (Kakkad, Kedia) pressed hard, got philosophical answers. Execution risk is real.

Vendor consolidation (200 bps uplift) is multi-year; near-term margin recovery contingent on ASP/channel only

Medium

120→30 partners over 3-5 years. Benefits not yet visible in Q2 numbers. Near-term margin expansion must come from pricing (ASP) and channel mix optimization (toward profitability in franchise model). Both have limits; upside capped.

Commodity/FX volatility uncontrollable; pricing increases may not fully offset cost inflation

Medium

CFO Amit Aggarwal explicit: margins 'range-bound' due to commodity and FX volatility. Price increases of 5-6% may not fully offset raw material inflation. If commodity prices spike, pricing power alone won't protect margins.

Competitive share loss and Gen-Z brand perception weak

Medium

Management acknowledges Bata not first choice for younger consumers. Missed sneaker trend; now playing catch-up against nimble competitors (Puma, Adidas, local brands gaining share). Brand decay with Gen-Z is a structural headwind; turnaround timeline unclear.

How the Street is Positioned

Price action, valuation, and institutional flows

Post-result price action

Current reading

Day 1: -2.55% (from ₹649.8 pre-result); Day 3: -1.81% (moves held, not faded)

What it means

Market unconvinced by the print. The move (-1.81% by day 3) has held steady, indicating no bounce-back. Street remains skeptical of volume recovery and earnings quality.

Current price

Current reading

₹638.05 (as of 2026-11-06)

What it means

Above SMA20 (₹633.84) but below SMA50 (₹640.85) and SMA200 (₹709.24). Technically weak; no support until the 52-week low.

52-week range & all-time high

Current reading

52w: ₹601–₹1,081.3 (now +6.16% off low, -41% from high). ATH: ₹2,262 (now -71.79%)

What it means

Valuation has compressed 72% from the peak. This reflects deep pessimism; the market has priced in structural headwinds (brand decay, volume stall, margin pressure). Further downside may be limited unless fundamentals deteriorate further, but upside requires credible volume recovery + margin re-expansion.

RSI

Current reading

50.1 (neutral)

What it means

No overbought or oversold condition. Stock is in equilibrium on momentum; directional shift depends on fundamental catalysts, not technical bounce.

Institutional ownership

Current reading

FII 6.38% (down 0.05pp QoQ), DII 27.23% (down 1.16pp QoQ), Promoter 50.16%

What it means

Both FII and DII are trimming, especially DII (down 1.16pp QoQ). Institutional disinterest is palpable. Promoter steady at 50.16%, but no buyback announced to support the stock.

Day-1 delivery (volume)

Current reading

50.4% (below normal)

What it means

Weak institutional follow-through on day 1; suggests low conviction selling into the result. Retail selling predominating.

What to Watch Next
  • 1 · H2 FY27 new product execution and volume recovery

    Q2 volume growth stalled at 1.5-2%. Management promised new product launches (sneaker category, global lines for Gen-Z) in H2 FY27 to drive volume acceleration. Q3 results (e-comm events post-Diwali, festive season trends) will be the first test. If volume doesn't accelerate to at least mid-single-digit growth, the 4-year CAGR ambition loses credibility. Watch for franchisee store count additions (double-digit target); execution on rollout will signal management capability.

  • 2 · Q3 net margin recovery

    Q2 NPM at 2.1% is razor-thin; PAT down 71.7% QoQ despite YoY growth. Is this the new baseline, or was Q2 hit by transient WC drag or one-time costs? Q3 net margin will be the tie-breaker. If it stays at 2.1% or lower, earnings quality concern is real. If it bounces to 3%+, the QoQ collapse was temporary and confidence in structural margin recovery improves. FX and commodity headwind direction (CFO cautious) will be key drivers.

  • 3 · Gross margin trajectory and vendor consolidation progress

    Gross margin up 70 bps Q1→Q2 is real, but offset by channel mix drag (franchisee/e-com lower-margin). The target is 200 bps uplift from vendor consolidation (120→30 partners) over 3-5 years. Q3-Q4 results will show whether gross margin expansion continues or plateaus. If it stalls, the 200 bps target is at risk; if it accelerates, consolidation is working as planned.

  • 4 · New MD's near-term credibility: milestones on brand recovery and Gen-Z positioning

    Sanjay Rao is building a narrative of 'global input + local execution' to restore brand relevance with Gen-Z. Watch for: (1) concrete product launches (sneaker lines, collaborations, category-specific pitches), (2) marketing investment effectiveness (A&P spend up 4%, targeting 3-3.5% of sales), (3) franchisee store quality and unit economics (are franchisees profitable?). Execution here will determine whether the 'double India 2030' ambition is credible or aspirational.

Bata is a mature heritage retailer in a weak-demand environment, deploying pricing power (+5-6% ASP) but facing stalled volume growth (~1.5-2%). The new MD brings fresh ambition ('double India 2030') and global perspective, but the 10-year execution track record is near-flat CAGR, creating a credibility gap that only quarterly execution can close.

Q2 delivered headline growth (revenue +7.5% YoY) entirely from ASP inflation. More troubling: PAT down 71.7% quarter-on-quarter to a razor-thin 2.1% net margin, despite gross margin expanding 70 bps. This suggests working capital drag or unspoken costs that management did not reconcile on the call, raising earnings quality concerns.

Structural plays—vendor consolidation (120→30 partners, 200 bps gross margin target), franchisee expansion, premiumization—are all multi-year and have not yet materialized. Near-term margin recovery is contingent on ASP and channel mix optimization, both of which have natural limits. Commodity and FX volatility remain uncontrollable headwinds.

The street has voted: FII and DII trimming holdings, post-result move (-1.81% by day 3) has held negative. The stock is 72% below its all-time high, 41% below its 52-week high. Valuation reflects deep pessimism; the risk/reward is balanced IF the new MD can prove execution capability on volume recovery and net margin normalization.

Rating: Hold. Confidence: 6/10. The single number to track from here is Q3 net margin recovery. If NPM bounces above 2.5%, the QoQ collapse was transient and structural thesis improves. If it stays flat or declines, earnings quality concern is confirmed and downside remains. Volume growth (e-comm recovery post-Diwali, new product impact) in Q3 will be the second tie-breaker. Until management proves execution credibility on both, the stock is fairly valued at a deep discount to its peak, but upside is capped.

Informational and educational content only. Not investment advice.